Works by Poligone, Brian


Results: 12
    1
    2
    3
    4

    Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma.

    Published in:
    Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15634
    By:
    • Bagot, Martine;
    • Dalle, Stéphane;
    • Sokol, Lubomir;
    • Tsianakas, Athansios;
    • Musiek, Amy;
    • Ortiz‐Romero, Pablo L.;
    • Poligone, Brian;
    • Duvic, Madeleine;
    • Elmets, Craig;
    • Leoni, Mollie;
    • Dwyer, Karen;
    • Ito, Takahiro;
    • Herr, Fiona;
    • Kim, Youn H.
    Publication type:
    Article
    5
    6

    HyBryte™ use in early-stage cutaneous T-cell lymphoma.

    Published in:
    Frontiers in Drug Discovery, 2023, p. 1, doi. 10.3389/fddsv.2023.1298453
    By:
    • Poligone, Brian;
    • Alexander-Savino, Carolina V.;
    • Kim, Ellen J.;
    • Mangold, Aaron R.;
    • Desimone, Jennifer;
    • Wong, Henry K.;
    • Rumage, Adam T.;
    • Donini, Oreola;
    • Haulenbeek, Andrea;
    • Schaber, Christopher J.;
    • Straube, Richard;
    • Pullion, Christopher;
    • Rook, Alain H.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12